GO:0008083 growth factor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008083 (growth factor activity) is a molecular function describing the capacity of a protein to stimulate a cell to grow or proliferate, and most growth factors have additional actions beyond growth induction.
• Growth factor activity is mediated by secreted or membrane-associated ligands that bind cell-surface receptors and trigger intracellular signaling cascades, including mTORC2, NFATc1-Stat3, and PAK2-dependent pathways.
• Exercise and physical activity can modulate circulating growth factor concentrations, linking this molecular function to systemic physiology and brain health.
• Proteolytic shedding of growth factor precursors by ADAM17, restrained by iRhom2, is a key regulatory node controlling growth factor release and inflammatory signals.
• Transcriptional activators can drive expression programs that include growth factor genes, making growth factor activity a downstream output of cell-state control.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of growth factor activity in human cells and animal models.
Description
Growth factor activity (GO:0008083) is a molecular function that stimulates a cell to grow or proliferate, and most growth factors have other actions besides the induction of cell growth or proliferation. This term captures the ligand-side function of proteins such as epidermal growth factor (EGF), fibroblast growth factors (FGFs), vascular endothelial growth factor (VEGF), and insulin-like growth factors (IGFs), which act as extracellular signals to coordinate tissue growth, survival, and differentiation. Because growth factor activity sits at the interface between the extracellular environment and intracellular signaling, it is central to developmental biology, cancer biology, immunology, and neuroscience. Mechanistically, growth factor activity is not a single enzymatic reaction but a receptor-mediated signaling function. Growth factors bind to cell-surface receptors, often receptor tyrosine kinases, and activate downstream cascades such as PI3K-AKT-mTORC2, MAPK, and STAT3. For example, growth factor-dependent and -independent activation of mTORC2 has been characterized as a key node integrating growth factor signals with metabolic and cytoskeletal outputs. In pancreatic acinar cells, gastrointestinal hormones, neurotransmitters, and growth factors can activate P21-activated kinase 2 (PAK2) through novel mechanisms, illustrating the breadth of growth factor-coupled signaling. Regulated release of growth factors is equally important. The metalloprotease ADAM17 cleaves membrane-bound growth factor precursors, and cryo-EM studies show that iRhom2 restrains ADAM17 protease activity to control the release of growth factor and inflammatory signals. This regulatory layer ensures that growth factor activity is spatially and temporally restricted. Physiologically, exercise builds brain health through growth factor cascades and inflammation modulation, and physical activity can alter growth factor concentrations in platelet-rich fibrin. Brown adipose tissue activation by exercise also involves growth factor-related signaling. Together, these findings establish GO:0008083 as a convergence point for cell biology, physiology, and disease research.
growth factor activity At A Glance
| GO ID | GO:0008083 |
|---|---|
| GO term | growth factor activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
| Major function | Receptor-mediated stimulation of cell growth and proliferation, often with additional roles in survival, differentiation, and inflammation. |
| Representative ligands | EGF, FGF, VEGF, IGF, and related secreted or membrane-bound growth factors. |
| Key regulatory node | ADAM17-mediated shedding restrained by iRhom2 controls release of growth factor signals. |
| Downstream pathways | mTORC2, NFATc1-Stat3, and PAK2-dependent signaling. |
| Physiological context | Exercise and physical activity modulate growth factor cascades and circulating growth factor concentrations. |
What Is GO:0008083?
In our own words, GO:0008083 (growth factor activity) is the function of a protein that stimulates a cell to grow or proliferate. The QuickGO definition notes that most growth factors have other actions besides the induction of cell growth or proliferation, meaning this term is not limited to mitogenic effects. It is a molecular_function term, so it describes what a gene product does at the molecular level rather than a biological process or cellular location. Growth factor activity is typically executed by secreted ligands or membrane-bound precursors that engage specific receptors and initiate intracellular signaling. Because the definition explicitly allows additional actions, proteins annotated to GO:0008083 may also regulate differentiation, survival, migration, inflammation, or metabolism.
Why Is growth factor activity Important in Cell Biology?
GO:0008083 is important because growth factor activity controls fundamental cell decisions such as whether to grow, proliferate, survive, or differentiate, and its dysregulation is implicated in cancer, inflammatory disease, metabolic disorders, and neurodegeneration. Because growth factors act as extracellular signals, they are accessible targets for therapeutic intervention and are widely studied in regenerative medicine, oncology, and exercise physiology. Understanding growth factor activity also requires integrating ligand release, receptor activation, and downstream signaling, making it a model function for systems-level research.
• Growth factor activity drives cell proliferation and is a hallmark of tissue growth and regeneration.
• Deregulated growth factor signaling can transform cells; NFATc1 activity transforms murine fibroblasts via an autocrine growth factor-mediated Stat3-dependent pathway.
• Growth factor release is controlled by proteolytic shedding; iRhom2 restrains ADAM17 to limit growth factor and inflammatory signals.
• Growth factor-dependent and -independent activation of mTORC2 links growth factor activity to metabolism and cytoskeletal regulation.
• Growth factors can activate PAK2 in pancreatic acinar cells, connecting growth factor activity to gastrointestinal and neuroendocrine signaling.
• Exercise-induced growth factor cascades contribute to brain health and inflammation modulation.
• Physical activity alters growth factor concentrations in platelet-rich fibrin, relevant to wound healing and regenerative therapies.
• Exercise activation of brown adipose tissue involves growth factor-related signaling, linking growth factor activity to energy metabolism.
• Transcriptional activators can control growth factor gene expression programs, making growth factor activity a downstream readout of transcriptional state.
• Growth factor activity is a tractable target for CRISPR-based functional genomics and therapeutic model development.
Molecular Mechanism of growth factor activity
Ligand biosynthesis and membrane presentation
In simple terms: Growth factors are made as precursor proteins that are often anchored in the cell membrane before being released.
Growth factor activity begins with the biosynthesis of growth factor precursors, many of which are type I transmembrane proteins that present the growth factor domain at the cell surface. These precursors can act in a membrane-bound form or be cleaved to release a soluble ligand. The balance between membrane-bound and soluble forms influences whether signaling is juxtacrine or paracrine. ADAM17 is a key sheddase for many growth factor precursors, and its activity is restrained by iRhom2, as shown by cryo-EM studies demonstrating that iRhom2 controls ADAM17 protease activity to regulate release of growth factor and inflammatory signals.
Proteolytic shedding and signal release
In simple terms: Enzymes cut growth factors off the cell surface so they can travel and bind receptors on other cells.
Proteolytic shedding is a regulated step that converts membrane-bound growth factor precursors into soluble ligands. ADAM17-mediated cleavage releases growth factors such as TGF-alpha and heparin-binding EGF-like growth factor, and this process is tightly controlled. The cryo-EM structure of the iRhom2-ADAM17 complex reveals how iRhom2 restrains ADAM17, preventing excessive release of growth factor and inflammatory signals. This regulatory mechanism ensures that growth factor activity is deployed only when appropriate, and its disruption can lead to uncontrolled signaling.
Receptor binding and activation
In simple terms: Growth factors bind to specific receptors on the cell surface, switching on signals inside the cell.
Soluble growth factors bind to cell-surface receptors, most commonly receptor tyrosine kinases (RTKs). Ligand binding induces receptor dimerization and autophosphorylation, creating docking sites for adaptor proteins. This initiates intracellular signaling cascades. Growth factor-dependent activation of mTORC2 is a well-characterized example, where growth factor signals feed into mTORC2 to regulate AKT phosphorylation and downstream metabolic and cytoskeletal responses. The specificity of growth factor activity depends on which ligand is released and which receptors are expressed on the target cell.
Downstream signaling cascades
In simple terms: Once the receptor is activated, a chain of proteins inside the cell relays the growth signal to the nucleus and other targets.
Receptor activation triggers multiple downstream pathways. Growth factor-dependent and -independent activation of mTORC2 represents one key axis. In murine fibroblasts, deregulated NFATc1 activity transforms cells via an autocrine growth factor-mediated Stat3-dependent pathway, showing how growth factor activity can feed into STAT3 signaling. In pancreatic acinar cells, gastrointestinal hormones, neurotransmitters, and growth factors can activate PAK2 through novel mechanisms, highlighting the diversity of growth factor-coupled kinases. These cascades ultimately regulate transcription factors, cell cycle progression, and cytoskeletal remodeling.
Transcriptional feedback and cell-state control
In simple terms: The cell can change how much growth factor it makes by turning genes on or off.
Growth factor activity is subject to transcriptional feedback. Transcriptional activators can drive expression of growth factor genes and their receptors, thereby shaping the cell's responsiveness. A systematic identification and functional characterization of transcriptional activators in human cells provides a framework for understanding how growth factor gene expression is controlled. This transcriptional layer allows cells to adapt their growth factor output to developmental, metabolic, or stress signals, and it is a common point of dysregulation in cancer.
Physiological modulation by exercise and systemic factors
In simple terms: Whole-body activities like exercise can change growth factor levels in the blood and tissues.
Growth factor activity is not only a cell-autonomous process; it is modulated systemically. Exercise builds brain health through growth factor cascades and inflammation modulation. Physical activity affects growth factor concentrations in platelet-rich fibrin, a clinically relevant matrix for wound healing. Exercise also activates brown adipose tissue through mechanisms that involve growth factor-related signaling. These findings show that growth factor activity integrates local signaling with systemic physiological state.
Key Genes Involved in GO:0008083 growth factor activity
The following genes and proteins are representative of growth factor activity (GO:0008083) and its regulatory network, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EGF | Prototypical growth factor ligand that binds EGFR and stimulates proliferation | Model ligand for studying growth factor activity and receptor tyrosine kinase signaling |
| ADAM17 | Metalloprotease that sheds membrane-bound growth factor precursors | Key sheddase controlling release of growth factor and inflammatory signals |
| RHBDF2 (iRhom2) | Pseudoprotease that restrains ADAM17 protease activity | Cryo-EM studies show iRhom2 controls growth factor release |
| MTOR | Kinase in mTORC1 and mTORC2 complexes integrating growth factor signals | Growth factor-dependent and -independent activation of mTORC2 |
| NFATC1 | Transcription factor activated by growth factor signaling | Deregulated NFATc1 transforms fibroblasts via autocrine growth factor-Stat3 pathway |
| STAT3 | Transcription factor downstream of growth factor and cytokine signaling | Mediates autocrine growth factor-driven transformation |
| PAK2 | P21-activated kinase activated by growth factors and neuroendocrine signals | Growth factors activate PAK2 in pancreatic acinar cells |
| VEGFA | Growth factor regulating angiogenesis | Representative growth factor with roles beyond proliferation |
| FGF2 | Growth factor involved in development and tissue repair | Model for growth factor activity in brain and systemic physiology |
| IGF1 | Growth factor mediating growth hormone effects | Circulating growth factor modulated by exercise |
| BDNF | Neurotrophic growth factor supporting neuronal survival and plasticity | Exercise-induced growth factor cascades in brain health |
| TGFB1 | Growth factor with context-dependent proliferative and anti-proliferative actions | Illustrates additional actions beyond growth induction |
| HGF | Growth factor promoting cell motility and proliferation | Relevant to tissue regeneration and cancer models |
| PDGFA | Growth factor for mesenchymal cells | Studied in platelet-rich fibrin and wound healing |
| EGFR | Receptor tyrosine kinase for EGF-family ligands | Central receptor mediating growth factor activity |
| FGFR1 | Receptor for FGF ligands | Model receptor for growth factor signaling |
| INSR | Receptor for insulin and IGF ligands | Links growth factor activity to metabolism |
How Is growth factor activity Regulated?
Growth factor activity is regulated at multiple levels. Proteolytic shedding by ADAM17 is restrained by iRhom2, which controls the release of growth factor and inflammatory signals. Downstream, growth factor-dependent and -independent activation of mTORC2 integrates growth factor signals with metabolic and cytoskeletal outputs. Autocrine loops involving NFATc1 and Stat3 can sustain growth factor signaling and drive transformation. In pancreatic acinar cells, growth factors can activate PAK2 through novel mechanisms, adding another layer of regulation. Systemically, exercise and physical activity modulate growth factor concentrations and cascades, linking physiological state to growth factor activity. Transcriptional activators can also regulate growth factor gene expression programs.
growth factor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NFATC1 | Oncogenic transformation via autocrine growth factor-Stat3 pathway | NFATC1 knockout and overexpression in murine fibroblasts |
| ADAM17 | Inflammatory signaling and growth factor release disorders | ADAM17 point-mutation and knockout in human cell lines |
| RHBDF2 (iRhom2) | Dysregulated ADAM17 activity and growth factor shedding | iRhom2 knockout and knock-in models |
| MTOR | Metabolic disorders and cancer via mTORC2 | MTOR knockout and point-mutation in growth factor-stimulated cells |
| PAK2 | Pancreatic acinar cell signaling and gastrointestinal disorders | PAK2 knockout in pancreatic acinar cell models |
Cancer and oncogenic transformation
Deregulated growth factor activity is a hallmark of cancer. Autocrine growth factor loops can drive constitutive proliferation and survival. In murine fibroblasts, deregulated NFATc1 activity transforms cells via an autocrine growth factor-mediated Stat3-dependent pathway, demonstrating that growth factor activity can be a direct driver of oncogenic transformation. Growth factor-dependent activation of mTORC2 further supports cancer cell metabolism and growth. Transcriptional activators that control growth factor gene expression can also contribute to oncogenic programs.
Inflammatory and shedding-related disorders
ADAM17-mediated shedding of growth factor precursors is a key regulatory node, and its dysregulation can cause excessive growth factor and inflammatory signaling. Cryo-EM studies show that iRhom2 restrains ADAM17 protease activity to control the release of growth factor and inflammatory signals. Loss of this restraint may contribute to inflammatory diseases and cancer, making the iRhom2-ADAM17 axis a potential therapeutic target.
Neurodegeneration and brain health
Growth factor cascades are important for brain health. Exercise builds brain health through growth factor cascades and inflammation modulation. Reduced growth factor activity has been associated with impaired neuronal survival and plasticity, and interventions that increase growth factor signaling, such as physical activity, are being studied for neuroprotection.
Metabolic and gastrointestinal disorders
Growth factor activity intersects with metabolic regulation. Growth factor-dependent and -independent activation of mTORC2 links growth factor signals to metabolism. In pancreatic acinar cells, growth factors can activate PAK2, connecting growth factor activity to gastrointestinal and neuroendocrine function. Exercise activation of brown adipose tissue also involves growth factor-related signaling, linking growth factor activity to energy balance.
From growth factor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate growth factor gene required for proliferation? | CRISPR knockout in human cell lines followed by growth assays |
| Does a specific point mutation alter growth factor secretion or receptor binding? | CRISPR point-mutation knock-in of the endogenous locus |
| Can a tagged growth factor be tracked in live cells? | Knock-in of fluorescent or epitope tag at the endogenous locus |
| Does overexpression of a growth factor drive transformation? | CRISPR-mediated overexpression or lentiviral overexpression in fibroblasts |
| Which transcriptional activators regulate growth factor genes? | CRISPR activation screens and transcriptomics |
| How does growth factor signaling feed into mTORC2? | Knockout of MTOR or pathway components with growth factor stimulation |
How to Study the growth factor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function of a growth factor gene | Testing requirement for proliferation or signaling |
| CRISPR point mutation | Effect of a specific amino acid change | Dissecting shedding or receptor-binding residues |
| CRISPR knock-in | Tagged or reporter growth factor expression | Live-cell imaging and localization |
| CRISPR overexpression | Gain-of-function of a growth factor | Testing transformation potential |
| Cryo-EM | Three-dimensional structure of protein complexes | Understanding iRhom2-ADAM17 regulation |
| Phospho-protein assays | Activation of signaling kinases | Measuring mTORC2, STAT3, or PAK2 activity |
| Transcriptomics | Gene expression changes | Identifying growth factor gene programs |
| Exercise physiology assays | Circulating growth factor concentrations | Linking physical activity to growth factor activity |
CRISPR functional genomics
CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of growth factor genes. Transcriptional activators can be identified and functionally characterized in human cells using CRISPR-based screens, providing a way to map regulators of growth factor gene expression. These approaches are essential for distinguishing correlation from causation in growth factor biology.
Biochemical and structural methods
Cryo-EM has been used to reveal how iRhom2 restrains ADAM17 protease activity to control growth factor release. Biochemical assays of shedding, receptor phosphorylation, and downstream kinase activation complement structural studies. These methods define the molecular mechanism of growth factor activity at atomic and biochemical resolution.
Cell signaling assays
Growth factor-dependent and -independent activation of mTORC2 can be measured by monitoring AKT phosphorylation and downstream substrates. Autocrine growth factor-Stat3 signaling can be assessed by STAT3 phosphorylation and transcriptional reporters. PAK2 activation in pancreatic acinar cells can be assayed by kinase activity and phospho-specific antibodies.
Physiological and exercise studies
Exercise and physical activity modulate growth factor cascades and circulating growth factor concentrations. These studies use human cohorts and animal models to link growth factor activity to systemic physiology, brain health, and brown adipose tissue activation. Platelet-rich fibrin provides a translational matrix for measuring growth factor concentrations after physical activity.
How CRISPR Can Be Used to Study GO:0008083 growth factor activity
Knockout
CRISPR knockout of growth factor genes or their regulators can reveal whether they are required for proliferation, survival, or signaling. For example, knocking out ADAM17 or iRhom2 can test their roles in growth factor release. Knockout of MTOR can dissect growth factor-dependent mTORC2 activation. Knockout of NFATC1 can test its role in autocrine growth factor-Stat3 transformation.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes to test the function of growth factor domains, cleavage sites, or receptor-binding interfaces. This is particularly useful for studying ADAM17 cleavage sites and iRhom2 regulatory residues. Point mutations can also be used to activate or inactivate signaling domains in growth factor receptors.
Knock-in
Knock-in of tags, reporters, or humanized alleles allows tracking of growth factor expression and localization. Tagged growth factors can be used to monitor shedding and receptor binding in live cells. Knock-in of disease-associated variants can model how specific mutations alter growth factor activity.
Overexpression
CRISPR-mediated overexpression or lentiviral overexpression can test whether increased growth factor activity is sufficient to drive proliferation or transformation. Overexpression of growth factors in fibroblasts can induce autocrine Stat3-dependent transformation. Overexpression models are also useful for producing growth factors for biochemical and structural studies.
How EDITGENE Supports growth factor activity Research
Researchers studying growth factor activity-related genes often need to determine whether a candidate gene is causally involved in growth, proliferation, or disease. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for growth factor activity research.
Frequently Asked Questions About growth factor activity
What is growth factor activity GO:0008083?
GO:0008083 is a molecular function term describing the function that stimulates a cell to grow or proliferate, and most growth factors have other actions besides the induction of cell growth or proliferation.
What genes are involved in growth factor activity?
Representative genes include EGF, ADAM17, RHBDF2 (iRhom2), MTOR, NFATC1, STAT3, PAK2, VEGFA, FGF2, IGF1, BDNF, and their receptors.
How is growth factor activity regulated?
It is regulated by proteolytic shedding, receptor activation, downstream kinases such as mTORC2, and transcriptional programs; iRhom2 restrains ADAM17 to control growth factor release.
What diseases are linked to growth factor activity?
Cancer, inflammatory disorders, neurodegeneration, and metabolic or gastrointestinal conditions have been linked to dysregulated growth factor activity.
How can CRISPR be used to study growth factor activity?
CRISPR knockout, point mutation, knock-in, and overexpression can test the causal role of growth factor genes and their regulators in cell models.
Does exercise affect growth factor activity?
Yes, exercise builds brain health through growth factor cascades and can alter circulating growth factor concentrations in platelet-rich fibrin.
What is the role of ADAM17 in growth factor activity?
ADAM17 is a metalloprotease that sheds membrane-bound growth factor precursors, and its activity is restrained by iRhom2.
How does mTORC2 relate to growth factor activity?
Growth factor-dependent and -independent activation of mTORC2 integrates growth factor signals with metabolic and cytoskeletal outputs.
Can growth factor activity be measured experimentally?
Yes, methods include phospho-protein assays, cryo-EM, transcriptomics, and exercise physiology assays.
What cell models are suitable for growth factor activity research?
Knockout, point-mutation, knock-in, and overexpression cell lines, as well as primary cells and animal models, are suitable.
Conclusion
GO:0008083 (growth factor activity) is a central molecular function that coordinates cell growth, proliferation, and diverse additional actions through receptor-mediated signaling. Its regulation by proteolytic shedding, downstream kinases such as mTORC2, and transcriptional programs makes it a rich area for mechanistic and translational research. Dysregulated growth factor activity contributes to cancer, inflammation, neurodegeneration, and metabolic disease, underscoring its clinical relevance. CRISPR-based models and functional genomics provide powerful tools to dissect growth factor activity and identify therapeutic targets.
References
- 1. Cotman CW et al.. 2007. Exercise builds brain health: key roles of growth factor cascades and inflammation.. Trends Neurosci 30(9):464-72 PMID: 17765329
- 2. Lu F et al.. 2024. Cryo-EM reveals that iRhom2 restrains ADAM17 protease activity to control the release of growth factor and inflammatory signals.. Mol Cell 84(11):2152-2165.e5 PMID: 38781971
- 3. Alerasool N et al.. 2022. Identification and functional characterization of transcriptional activators in human cells.. Mol Cell 82(3):677-695.e7 PMID: 35016035
- 4. Yucel E et al.. 2026. The effect of physical activity on growth factor concentrations in platelet-rich fibrin: a cross-sectional study.. J Appl Oral Sci 34:e20260128 PMID: 42484239
- 5. Knudsen JR et al.. 2020. Growth Factor-Dependent and -Independent Activation of mTORC2.. Trends Endocrinol Metab 31(1):13-24 PMID: 31699566
- 6. Lagunas L et al.. 2009. Deregulated NFATc1 activity transforms murine fibroblasts via an autocrine growth factor-mediated Stat3-dependent pathway.. J Cell Biochem 108(1):237-48 PMID: 19565565
- 7. Nuche-Berenguer B et al.. 2015. Gastrointestinal hormones/neurotransmitters and growth factors can activate P21 activated kinase 2 in pancreatic acinar cells by novel mechanisms.. Biochim Biophys Acta 1853(10 Pt A):2371-82 PMID: 25979836
- 8. Sanchez-Delgado G et al.. 2015. Role of Exercise in the Activation of Brown Adipose Tissue.. Ann Nutr Metab 67(1):21-32 PMID: 26227180